BrightSpring Health Services opened lower at $60.05, compared with its previous close of $60.22. In the last trading session, the stock traded between $59.45 and $61.96. It showed a sideways intraday trend.
return calculator
Time Period
An investment of $100 made 3 years ago in BrightSpring Health Services is now worth
$ 548.91
giving a profit of
$ 448.91 (448.91%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 12 Analysts
Buy
100%
Hold
0%
Sell
0%
Markets Today
Today's Change
+$0.16 (+0.27%)
Day High
$61.96
Day Low
$59.45
Day Open
$60.05
Prev Close
$60.22
Volume
31,68,118
1W Return
-0.79%
1M Return
8.39%
3M Return
-12.94%
6M Return
25.40%
1Y Return
77.33%
Fundamentals
Market Cap ($ Mn)
11,947
PE Ratio
52.31
PB Ratio
5.70
PEG Ratio
1.21
ROE
5.97%
ROCE
6.59%
EPS (TTM)
$0.43
Investment Returns
1 Week
-0.79%
1 Month
8.39%
3 Months
-12.94%
6 Months
25.40%
9 Months
51.59%
Financials
Quarterly
All values in $ Mn
2.9K
Mar 25
3.1K
Jun 25
3.3K
Sep 25
3.6K
Dec 25
3.6K
Mar 26
3.9K
Jun 26
Updates
1Oct
BrightSpring Health Services to announce Q3FY26 results on Oct 30
BrightSpring Health Services plans to release Q3FY26 financial results on October 30, 2026. Earnings conference call scheduled for 8:30 am ET on the same day. Webcast available via investor relations website with pre-call presentation materials. Company serves over 485,000 patients daily across all 50 states.
29 days ago
31Jul
BrightSpring Health net income jumps to $87 million in Q2 2026
BrightSpring Health Services delivered strong Q2 2026 results with net income rising to $87 million and revenue increasing 23% to $3.873 billion. Adjusted EBITDA grew 44% to $206 million, driven by pharmacy margin expansion and provider volume gains. The company reduced leverage to 2.15x and raised full-year guidance.
3mo ago
31Jul
BrightSpring Health raises FY26 sales guidance above estimates
BrightSpring Health raised its FY2026 sales guidance to $15.100B-$15.425B from $14.725B-$15.225B. The new outlook exceeds the $15.064B estimate, indicating strong operational momentum.
3mo ago
14Jul
Morgan Stanley raises BrightSpring Health target to $80
Morgan Stanley analyst Erin Wright maintained an Overweight rating on BrightSpring Health, raising the price target to $80 from $71. The update aligns with positive sentiment from other firms, including Keybanc and Wells Fargo.
3mo ago
9Jul
BrightSpring Health Services to announce Q2 2026 results on July 31
BrightSpring Health Services will announce its Q2 2026 financial results on July 31, 2026, followed by an earnings conference call at 8:30 a.m. ET. The company provides specialized healthcare services across 50 states.
3mo ago
9Jul
UBS raises BrightSpring Health price target to $85
UBS analyst A.J. Rice maintained a Buy rating on BrightSpring Health, increasing the price target to $85 from $63, reflecting a positive outlook on the company's performance.
